5-Methyl phenazine-1-carboxylic acid: A novel bioactive metabolite by a rhizosphere soil bacterium that exhibits potent antimicrobial and anticancer activities
Tài liệu tham khảo
Shanmugaiah, 2010, Purification, crystal structure and antimicrobial activity of phenazine-1-carboxamide produced by a growth-promoting biocontrol bacterium, Pseudomonas aeruginosa MML2212, J. Appl. Microbiol., 108, 703, 10.1111/j.1365-2672.2009.04466.x
Shanahan, 1992, Isolation of 2,4-diacetylphloroglucinol from a fluorescent pseudomonad and investigation of physiological parameters influencing its production, Appl. Environ. Microbiol., 58, 353, 10.1128/AEM.58.1.353-358.1992
Keel, 1990, Pseudomonads as antagonists of plant pathogens in the rhizosphere: role of the antibiotic 2,4-diacetylphloroglucinol in the suppression of black root rot of tobacco, Symbiosis, 9, 327
de Souza, 2003, Polymorphisms within the prnD and pltC genes from pyrrolnitrin and pyoluteorin-producing Pseudomonas and Burkholderia spp., FEMS Microbiol. Ecol., 43, 21, 10.1111/j.1574-6941.2003.tb01042.x
Kraus, 1995, Characterization of a genomic region required for production of the antibiotic pyoluteorin by the biological control agent Pseudomonas fluorescens Pf-5, Appl. Environ. Microbiol., 61, 849, 10.1128/AEM.61.3.849-854.1995
de Bruijn, 2008, Massetolide A biosynthesis in Pseudomonas fluorescens, J. Bacteriol., 190, 2777, 10.1128/JB.01563-07
Blumer, 2000, Mechanism, regulation, and ecological role of bacterial cyanide biosynthesis, Arch. Microbiol., 173, 170, 10.1007/s002039900127
O’Sullivan, 1992, Traits of fluorescent Pseudomonas spp. involved in suppression of plant root pathogens, Microbiol. Rev., 56, 662, 10.1128/MMBR.56.4.662-676.1992
Jimenez, 2012, The multiple signaling systems regulating virulence in Pseudomonas aeruginosa, Microbiol. Mol. Biol. Rev., 76, 46, 10.1128/MMBR.05007-11
Laursen, 2004, Phenazine natural products: biosynthesis, synthetic analogues, and biological activity, Chem. Rev., 104, 1663, 10.1021/cr020473j
Mavrodi, 2006, Phenazine metabolites in fluorescent Pseudomonas spp. biosynthesis and regulation, Annu. Rev. Phytopathol., 44, 417, 10.1146/annurev.phyto.44.013106.145710
Kumar, 2005, Characterization of antifungal metabolite produced by a new strain Pseudomonas aeruginosa PUPa3 that exhibits broad-spectrum antifungal activity and biofertilizing traits, J. Appl. Microbiol., 98, 145, 10.1111/j.1365-2672.2004.02435.x
Hussain, 2011, A new class of phenazines with activity against a chloroquine resistant Plasmodium falciparum strain and antimicrobial activity, J. Med. Chem., 54, 4913, 10.1021/jm200302d
Neves-Pinto, 2002, A trypanocidal phenazine derived from β-lapachone, J. Med. Chem., 45, 2112, 10.1021/jm010377v
Wang, 2000, Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules, Bioorg. Med. Chem. Lett., 10, 1151, 10.1016/S0960-894X(00)00217-1
Rewcastle, 1987, Potential antitumor agents. 51. Synthesis and antitumor activity of substituted phenazine-1-carboxamides, J. Med. Chem., 30, 843, 10.1021/jm00388a017
Abdelfattah, 2011, Isolation and structure elucidation of izuminosides A–C: a rare phenazine glycosides from Streptomyces sp. IFM 11260, J. Antibiot., 64, 271, 10.1038/ja.2010.172
Wang, 2002, Structure-activity relationship for analogues of the phenazine-based dual topoisomerase I/II inhibitor XR11576, Bioorg. Med. Chem. Lett., 11, 415, 10.1016/S0960-894X(01)00770-3
Gao, 2013, Synthesis and anticancer activity of some novel 2-phenazinamine derivatives, Eur. J. Med. Chem., 69, 1, 10.1016/j.ejmech.2013.07.017
Hanahan, 2011, Hallmarks of cancer: next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013
Hannun, 1997, Apoptosis and the dilemma in cancer chemotherapy, Blood, 189, 1845, 10.1182/blood.V89.6.1845
Huang, 2001, Signalling pathways in apoptosis as potential target for cancer therapy, Trends Cell Biol., 11, 343, 10.1016/S0962-8924(01)02063-3
King, 1954, Two simple media for demonstration of pyocyanin and fluorescein, J. Lab. Clin. Med., 44, 301
Sakthivel, 1987, Evaluation of Pseudomonas fluorescens for suppression of sheath-rot disease and for enhancement of grain yields in rice (Oryza sativa L.), Appl. Environ. Microbiol., 53, 2056, 10.1128/AEM.53.9.2056-2059.1987
Ayyadurai, 2006, Isolation and characterization of a novel banana rhizosphere bacterium as fungal antagonist and microbial adjuvant in micropropagation of banana, J. Appl. Microb., 100, 926, 10.1111/j.1365-2672.2006.02863.x
Naik, 2008, Genetic and functional diversity among fluorescent pseudomonads isolated from the rhizosphere of banana, Microb. Ecol., 56, 492, 10.1007/s00248-008-9368-9
Gurusiddaiah, 1986, Characterization of an antibiotic produced by a strain of Pseudomonas fluorescens inhibitory to Gaeumannomyces graminis var. tritici and Pythium spp., Antimicrob. Agents Chemother., 29, 488, 10.1128/AAC.29.3.488
Sathya, 2010, 3β-Hydroxylup-20(29)-ene-27,28-dioic acid dimethyl ester, a novel natural product from Plumbago zeylanica inhibits the proliferation and migration of MDA MB-231 cells, Chem. Biol. Interact., 188, 412, 10.1016/j.cbi.2010.07.019
Gayathri, 2007, Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophage through inhibition of TNF-α, IL-1β, NO and MAP Kinase, Int. Immunopharmcol., 7, 473, 10.1016/j.intimp.2006.12.003
Fan, 2006, Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells, Bioorg. Med. Chem., 14, 3218, 10.1016/j.bmc.2005.12.035
Senthil, 2007, Withanolide induces apoptosis in HL-60 leukemia cells via mitochondria mediated cytochrome c release and caspase activation, Chem-Biol. Interact., 167, 19, 10.1016/j.cbi.2007.01.004
Friesner, 2004, Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy, J. Med. Chem., 47, 1739, 10.1021/jm0306430
Friesner, 2006, Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes, J. Med. Chem., 49, 6177, 10.1021/jm051256o
Halgren, 2004, Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening, J. Med. Chem., 47, 1750, 10.1021/jm030644s
Mills, 2006, ChemDraw Ultra 10.0, J. Am. Chem. Soc., 128, 13649, 10.1021/ja0697875
Pettersen, 2004, Chimera a visualization system for exploratory research and analysis TE, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084
Chin-A-Woeng, 2000, Root colonization by phenazine-1-carboxamide-producing bacterium Pseudomonas chlororaphis PCL1391 is essential for biocontrol of tomato foot and root rot, Mol. Plant Microbe Interact., 13, 1340, 10.1094/MPMI.2000.13.12.1340
Chin-A-Woeng, 2000, Introduction of the phzH gene of Pseudomonas chlororaphis PCL1391 extends the range of biocontrol ability of phenazine-1-carboxylic acid-producing Pseudomonas spp. Strains, Mol. Plant Microbe Interact., 14, 1006, 10.1094/MPMI.2001.14.8.1006
Weller, 2007, Role of 2,4-diacetylphloroglucinol producing fluorescent Pseudomonas spp. in the defense of plant roots, Plant Biol., 9, 4, 10.1055/s-2006-924473
Gibson, 2009, Pseudomonas aeruginosa-Candida albicans interactions: localization and fungal toxicity of a phenazine derivative, Appl. Environ. Microbiol., 75, 504, 10.1128/AEM.01037-08
Hansford, 1972, Pigments of Pseudomonas species. Part IV. in vitro and in vivo conversion of 5-methylphenazinium-1-carboxylate into aeruginosin A, J. Chem. Soc. Perkin Trans., 1, 103, 10.1039/p19720000103
Cimmino, 2012, Phenazines and cancer, Nat. Prod. Rep., 29, 387, 10.1039/c2np00079b
Kondratyuk, 2012, Novel marine phenazines as potential cancer chemopreventive and anti-inflammatory agents, Mar. Drugs, 10, 451, 10.3390/md10020451
Stewart, 2003, Cell cycle dysregulation and anticancer therapy, Trends Pharmacol. Sci., 24, 139, 10.1016/S0165-6147(03)00026-9
Vermeulen, 2003, The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer, Cell Prolif., 36, 131, 10.1046/j.1365-2184.2003.00266.x
Thornberry, 1998, Caspases: key mediators of apoptosis, Chem. Biol., 5, 97, 10.1016/S1074-5521(98)90615-9
Zhivotovsky, 2003, Defects in the apoptotic machinery of the cancer cells: role in drug resistance, Semin. Cancer Biol., 13, 125, 10.1016/S1044-579X(02)00130-X
Ghobrial, 2005, Targeting apoptosis pathways in cancer therapy, CA Cancer J. Clin., 55, 178, 10.3322/canjclin.55.3.178
Mashima, 2005, Defects of the apoptotic pathway as therapeutic target against cancer, Drug Resist. Updat., 8, 339, 10.1016/j.drup.2005.11.001
Hengartner, 2000, The biochemistry of apoptosis, Nature, 407, 770, 10.1038/35037710
Kasibhatla, 2003, Why target apoptosis in cancer treatment, Mol. Cancer Ther., 2, 573